Tierra Biosciences offers an advanced AI-powered platform designed for the rapid synthesis and purification of custom proteins, significantly enhancing the efficiency of protein production compared to traditional cell-based methods. Their Tierra Protein Platform facilitates a streamlined process where users can input amino acid sequences through an online portal, leading to the quick generation of high-quality, purified proteins. The platform employs cell-free synthesis, allowing for the manipulation of complex biological systems and the production of proteins in varying quantities, from micrograms to grams. This capability is complemented by real-time data integration, ensuring reproducibility and reliability in results, which is crucial for scientific research and development.

The company leverages generative AI models to generate extensive data points, optimizing the design and testing cycles for biological systems. Their technology encompasses DNA assembly, condition optimization, and automated high-throughput synthesis, all aimed at minimizing errors and enhancing the predictability of biological designs. By integrating various tools and tracking data, Tierra Biosciences ensures that researchers can achieve consistent outcomes, thereby accelerating the pace of discovery in protein-related applications. This comprehensive approach positions Tierra as a leader in the field of custom protein synthesis, catering to the needs of researchers looking for efficient and scalable solutions.

United States

The Tierra platform allows researchers to produce a wide diversity of proteins, including ones that are difficult or impossible to produce in common types of laboratory cells.

Tierra Biosciences

Company Details